143 related articles for article (PubMed ID: 7829131)
1. Overrepresentation of the V kappa IV subgroup in light chain deposition disease.
Denoroy L; Déret S; Aucouturier P
Immunol Lett; 1994 Sep; 42(1-2):63-6. PubMed ID: 7829131
[TBL] [Abstract][Full Text] [Related]
2. Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.
Rocca A; Khamlichi AA; Aucouturier P; Noël LH; Denoroy L; Preud'homme JL; Cogné M
Clin Exp Immunol; 1993 Mar; 91(3):506-9. PubMed ID: 7680298
[TBL] [Abstract][Full Text] [Related]
3. Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease.
Decourt C; Cogné M; Rocca A
Clin Exp Immunol; 1996 Nov; 106(2):357-61. PubMed ID: 8918585
[TBL] [Abstract][Full Text] [Related]
4. Novel human light chain V kappa segment: serologic and structural analyses of the kappa III-like Bence Jones protein and IgG kappa light chain REE.
Prelli F; Tummolo D; Solomon A; Frangione B
J Immunol; 1986 Jun; 136(11):4169-73. PubMed ID: 2422275
[TBL] [Abstract][Full Text] [Related]
5. The V kappa III subgroup light chain proteins in AL amyloidosis & autoimmune diseases.
Alim MA; Hara Y; Kaji H; Shinoda T
Indian J Med Res; 2001 Jul; 114():30-5. PubMed ID: 11762204
[TBL] [Abstract][Full Text] [Related]
6. Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.
Khamlichi AA; Aucouturier P; Silvain C; Bauwens M; Touchard G; Preud'homme JL; Nau F; Cogné M
Clin Exp Immunol; 1992 Jan; 87(1):122-6. PubMed ID: 1733627
[TBL] [Abstract][Full Text] [Related]
7. Primary structure of the variable part of an amyloidogenic Bence-Jones Protein (Mev.). An unusual insertion in the third hypervariable region of a human kappa-immunoglobulin light chain.
Eulitz M; Linke RP
Hoppe Seylers Z Physiol Chem; 1982 Nov; 363(11):1347-58. PubMed ID: 6816713
[TBL] [Abstract][Full Text] [Related]
8. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients.
Messiaen T; Deret S; Mougenot B; Bridoux F; Dequiedt P; Dion JJ; Makdassi R; Meeus F; Pourrat J; Touchard G; Vanhille P; Zaoui P; Aucouturier P; Ronco PM
Medicine (Baltimore); 2000 May; 79(3):135-54. PubMed ID: 10844934
[TBL] [Abstract][Full Text] [Related]
9. Light chain cardiomyopathy. Structural analysis of the light chain tissue deposits.
Gallo G; Goñi F; Boctor F; Vidal R; Kumar A; Stevens FJ; Frangione B; Ghiso J
Am J Pathol; 1996 May; 148(5):1397-406. PubMed ID: 8623912
[TBL] [Abstract][Full Text] [Related]
10. Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.
Cogné M; Preud'homme JL; Bauwens M; Touchard G; Aucouturier P
J Clin Invest; 1991 Jun; 87(6):2186-90. PubMed ID: 1904072
[TBL] [Abstract][Full Text] [Related]
11. Analysis of monoclonal immunoglobulin light chains in urine using two-dimensional electrophoresis.
Tichý M; Stulík J; Kovárová H; Matĕja F; Urban P
Neoplasma; 1995; 42(1):31-4. PubMed ID: 7617072
[TBL] [Abstract][Full Text] [Related]
12. Structural studies of three IgG kappa proteins from a patient with multiple myeloma.
Dworsky E; Sletten K; Harboe M; Wetteland P
Scand J Immunol; 1980; 12(4):281-7. PubMed ID: 6781064
[TBL] [Abstract][Full Text] [Related]
13. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
[TBL] [Abstract][Full Text] [Related]
14. Biclonal gammopathy of kappa light chain type in a case of multiple myeloma.
Rabhi H; Ghaffor M; Abbadi MC
Arch Inst Pasteur Alger; 1989; 57():141-50. PubMed ID: 2518743
[TBL] [Abstract][Full Text] [Related]
15. Serologically defined V region subgroups of human lambda light chains.
Solomon A; Weiss DT
J Immunol; 1987 Aug; 139(3):824-30. PubMed ID: 3110284
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.
Vidal R; Goñi F; Stevens F; Aucouturier P; Kumar A; Frangione B; Ghiso J; Gallo G
Am J Pathol; 1999 Dec; 155(6):2009-17. PubMed ID: 10595931
[TBL] [Abstract][Full Text] [Related]
17. Serum immunoglobulin free light chains in patients with monoclonal gammapathies.
Lubimova NV; Turko TA; Votyakova OM; Kushlinskii NE
Bull Exp Biol Med; 2012 Jun; 153(2):249-54. PubMed ID: 22816095
[TBL] [Abstract][Full Text] [Related]
18. Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.
Abraham RS; Clark RJ; Bryant SC; Lymp JF; Larson T; Kyle RA; Katzmann JA
Clin Chem; 2002; 48(4):655-7. PubMed ID: 11901068
[No Abstract] [Full Text] [Related]
19. A double monoclonal IgG1 kappa and IgG2 kappa in a single myeloma patient. Variation in clonal products and therapeutic responses.
Goñi F; Chuba J; Buxbaum J; Frangione B
J Immunol; 1988 Jan; 140(2):551-7. PubMed ID: 3121749
[TBL] [Abstract][Full Text] [Related]
20. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
Turesson I; Grubb A
Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
